Ischemic acute renal failure (ARF) is the most common form of ARF in the adult population. The molecular mechanisms of tubular regeneration after ischemic renal injury remain largely unknown. An understanding of the mechanisms that lead to renal cell proliferation and regeneration will be necessary for the exploration of novel therapeutic strategies for the treatment of ARF. It has been suggested that regeneration processes may recapitulate developmental processes in order to restore organ or tissue function. The adult tubular epithelial cells have a potent ability of regenerate after cellular damage. We examined functional role of two developmental genes, Wnt-4 and Ets-1, in renal tubular regeneration in ARF. The Wnt-b-catenin pathway plays key roles in embryogenesis. Wnt-4 is known to be expressed in the mesonephric duct in the embryonic development. To clarify the significance of the Wnt-4-b-catenin pathway in ARF, we used a rat ARF model in vivo and LLC-PK1 cells as an in vitro model. After clamping left rat renal artery for 1 hour, we examined whole kidney homogenate and total RNA extracted at 3, 6, 12, 24, 48, and 72 hours after reperfusion by Western blot analysis and real-time reverse transcriptionpolymerase chain reaction (RT-PCR). Wnt-4 mRNA and protein expression were strongly increased at 3 to 12 hours and 6 to 24 hours after ischemia, respectively. In immunohistologic examination, Wnt-4 was expressed in the proximal tubules and coexpressed with aquaporin 1 and proliferating cell nuclear antigen (PCNA). Cyclin D1 and cyclin A were expressed at 12 to 48 hours after reperfusion. Furthermore, overexpression of Wnt-4 and b-catenin promoted the cell cycle and increased the promoter activity and protein expression of cyclin D1 and cyclin A in LLC-PK1 cells. These data suggest that the Wnt-4-b-catenin pathway plays a key role in the cell cycle progression of renal tubules in ARF. The Ets family of transcription factors is defined by a conserved DNA-binding Ets domain that forms a winged helix-turn-helix structure motif. The Ets family is involved in a diverse array of biologic functions, including cellular growth, migration, and differentiation. To clarify the significance of Ets-1 in ARF, we used a rat ARF model in vivo and LLC-PK1 cells as an in vitro model. Ets-1 mRNA and protein expression were strongly increased at 3 to 12 hours and 6 to 24 hours after the ischemia, respectively. In the immunohistologic examination, Ets-1 was expressed in the proximal tubules and coexpressed with PCNA. Furthermore, overexpression of Ets-1 promoted the cell cycle and increased the promoter activity and protein expression of cyclin D1 in LLC-PK1 cells. Ets-1 promoter activity increased between 3 hours and 6 hours in hypoxia, and hypoxia also induced changes in the Ets-1 protein level in LLC-PK1 cells. Taken together, these data suggest that Ets-1 plays a key role in the cell cycle progression of renal tubules in ARF. Our data suggest that Wnt-4-b-catenin and Ets-1 pathways regulate the transcription of cyclin D1 and control the regeneration of renal tubules in ARF. These developmental genes may play key roles in dedifferentiation and regeneration of the renal tubular cells after ARF. Kidneys can recovery from some type of injury. After an acute glomerulonephritis or a short-term ischemia, damaged glomerulus or tubules recover their normal structures with proliferation of the survived cells and infiltration of extrarenal cells. On the other hand, a prolonged or continuous injury leads to a progressive renal disease. We have investigated molecular events in reversible and irreversible renal diseases and have made efforts to identify genes pivotal in promoting regeneration or progression of the renal diseases. To identify genes responsible for kidney regeneration, we surveyed the expression pattern of the "development" genes in ischemia-reperfusion model of rat kidney. The regeneration, molding, and maturation of the restored epithelium after renal ischemia injury have many parallels to the growth and maturation that takes place during kidney organogenesis. We found that leukemia inhibitory factor (LIF) and its receptor (LIFR) expression were up-regulated during the recovery phase after ischemia insult. The increased expression of LIF and LIFR was most marked in the outer medulla, especially in the S3 segment of the proximal tubules. In cultured rat renal epithelial NRK52E cells, LIF expression was enhanced during recovery after adenosine triphosphate (ATP) depletion. Blockade of endogenous LIF with a neutralizing antibody significantly reduced the cell number and DNA synthesis during the recovery period. These results suggest that LIF participates in the regeneration process after tubular injury [Yoshino J, Monkawa T, Tsuji M, et al: Leukemia inhibitory factor is involved in tubular regeneration after experimental acute renal failure. J Am Soc Nephrol 14:3090-3101, 2003]. To search for genes playing important roles in progression of renal diseases, we compared gene expression profiles between an irreversible model and a reversible model of anti-Thy-1 glomerulonephritis using a microarray technology. A single intravenous injection of anti-Thy-1 monoclonal antibody 1-22-3 is known to cause a reversible mesangial proliferative glomerulonephritis. However, monoclonal antibody 1-22-3 injection followed by unilateral nephrectomy leads to progressive glomerulosclerosis with an irreversible course. Among 4854 rat genes on the microarray slide, 189 genes were differentially expressed. The differentially expressed genes were classified into five clusters based on their expression patterns. One of the clusters included genes the expression of which was markedly up-regulated in
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Kidneys can recovery from some type of injury. After an acute glomerulonephritis or a short-term ischemia, damaged glomerulus or tubules recover their normal structures with proliferation of the survived cells and infiltration of extrarenal cells. On the other hand, a prolonged or continuous injury leads to a progressive renal disease. We have investigated molecular events in reversible and irreversible renal diseases and have made efforts to identify genes pivotal in promoting regeneration or progression of the renal diseases. To identify genes responsible for kidney regeneration, we surveyed the expression pattern of the "development" genes in ischemia-reperfusion model of rat kidney. The regeneration, molding, and maturation of the restored epithelium after renal ischemia injury have many parallels to the growth and maturation that takes place during kidney organogenesis. We found that leukemia inhibitory factor (LIF) and its receptor (LIFR) expression were up-regulated during the recovery phase after ischemia insult. The increased expression of LIF and LIFR was most marked in the outer medulla, especially in the S3 segment of the proximal tubules. In cultured rat renal epithelial NRK52E cells, LIF expression was enhanced during recovery after adenosine triphosphate (ATP) depletion. Blockade of endogenous LIF with a neutralizing antibody significantly reduced the cell number and DNA synthesis during the recovery period. These results suggest that LIF participates in the regeneration process after tubular injury [Yoshino J, Monkawa T, Tsuji M, et al: Leukemia inhibitory factor is involved in tubular regeneration after experimental acute renal failure. J Am Soc Nephrol 14:3090-3101, 2003]. To search for genes playing important roles in progression of renal diseases, we compared gene expression profiles between an irreversible model and a reversible model of anti-Thy-1 glomerulonephritis using a microarray technology. A single intravenous injection of anti-Thy-1 monoclonal antibody 1-22-3 is known to cause a reversible mesangial proliferative glomerulonephritis. However, monoclonal antibody 1-22-3 injection followed by unilateral nephrectomy leads to progressive glomerulosclerosis with an irreversible course. Among 4854 rat genes on the microarray slide, 189 genes were differentially expressed. The differentially expressed genes were classified into five clusters based on their expression patterns. One of the clusters included genes the expression of which was markedly up-regulated in the irreversible model. The expression levels of the genes belonging to the cluster were low in normal kidney and increased along with disease peaked at day 14, and the up-regulation was more pronounced in the irreversible model than the reversible model. This cluster included collagen type1, laminin, osteopontin, kidney injury molecule-1 (KIM-1), and thymosin b10. These molecules can be new therapeutic targets for slowing the progression of renal diseases or accelerating repair of the injured kidney.
Epithelial-mesenchymal transition (EMT) is a process whereby epithelial cell layers lose polarity and cell-cell contacts and undergo a massive cytoskeleton reorganization involving the rho family and the remodeling of the actin microfilament mesh (Thiery, 2002) . Concurrent with a loss of epithelial cell adhesion and cytoskeletal components, cells undergoing EMT acquire expression of mesenchymal components and manifest a migratory phenotype. This is a fundamental process governing morphogenesis in multicellular organisms during embryonic development. This EMT process, first appreciated by developmental biologists in the early 1980s, is now attracting increasing attention from oncologists and nephrologists, because the process is also reactivated in a variety of diseases, including fibrosis and in the progression of carcinoma. From a therapeutic standpoint, it may be important to reverse EMT in these diseases. EMT is characterized by coordinated changes in cell morphology, associated with the induction of cell motility and the disruption of intercellular junctions. In some cases, cells undergoing EMT start synthesizing extracellular matrix molecules such as fibronectin and certain types of collagen. They may also synthesize proteolytic enzymes involved in matrix degradation that contribute to cell motility and invasiveness. It should be stressed that not all EMTs exhibit the whole range of changes listed here. However, EMT is always associated with cell scattering, defined by the loss of intercellular junctions and acquisition of cell motility. The transformation of mesenchyme to epithelium (MET), the reverse of EMT, also occurs during embryonic development. The differentiation of the metanephric blastema provides a striking example of MET. The cardinal feature of kidney development is the formation of epithelial tubules from nonepithelial mesenchymal cells. This conversion of cell type, MET, is controlled by factors secreted from the ureteric bud (Barasch, 1999; Plisov, 2001) , and these epithelial inducers have been purified from ureteric bud cell lines (Barasch, 1996) . These molecules are endogeneous MET inducers. We have tested some of these [bone morphogenetic protein 7(BMP-7) and lipocalin 2] for their epithelial inducing activities in the context of tumor biology and fibrosis and these results with potential therapeutic applications have been discussed. MUC20, a novel mucin protein highly expressed in kidney, was isolated as an up-regulated gene in renal tissues of patients with IgA nephropathy (IgAN) (J Biol Chem 279:1968 , 2004 . Functional analyses of MUC20 have demonstrated its role as a negative regulator of hepatocyte growth factor (HGF)-induced Grb2-Ras pathway. The C-terminus of MUC20 associates with the multifunctional docking site of Met, preventing Grb2 recruitment to Met and thus attenuating HGF-induced proliferation and matrix metalloproteinase expression (Mol Cell Biol 24:7456, 2004 ). In addition, it has been suggested that the oligomerization of MUC20, caused by its overproduction or some other unknown factor(s), which leads to this association with Met. Interestingly, in human MUC20, the repeat numbers of the extracellular tandem domain, which may have an influence on the oligomerization, showed a divergence, with two to six repeat types in several human cell lines. In this study, to clarify the role of MUC20 in human kidney diseases, we analyzed the expression of MUC20 in kidney tissues of patients with IgAN by in situ hybridization. We also investigated the possible association of the tandem repeat polymorphism of MUC20 with renal survival in 236 patients with histologically proven IgAN. In normal kidneys, the expression of MUC20 was confined to the distal tubules, where Met was colocalized by immunohsitochemistry. In addition, glomerular podocytes and the parietal epithelial cells lining Bowman's capsule demonstrated positive expression of MUC20. In renal tissues of IgAN, up-regulation of MUC20 expression in proximal tubules, as well as in distal tubules, was observed. By Kaplan-Meier analysis, the prognosis of IgAN patients with five or six of tandem repeat of MUC20 (N = 130) was significantly better than those without (N = 106, log-rank, v 2 = 10.51) (P = 0.0012). The tandem repeat polymorphism of MUC20 was an independent risk factor for
